Health Care › BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

CRBU Stock Price Correlated With Caribou Biosciences Financials

CRBU Stock Price vs. Quarterly

Enable JavaScript to see charts like this:

log linear

Income Statement

Cash Flow

Balance Sheet

CRBU Income Statement

Enable JavaScript and reload

Revenue, Net:

Revenue Per Share:

Cost of Goods & Services Sold:

Gross Profit:

Selling, General & Admin Expense:

Research & Development Expense:

Total Operating Expenses:

Operating Income:

Income Taxes:

Net Income:

Earnings Per Share, Diluted:

Earnings Per Share, Basic:

Shares Outstanding, Basic Avg:

Shares Outstanding, Diluted Avg:

Common Stock Shares Outstanding:

CRBU Cash Flow

Enable JavaScript and reload

Operating Activities Net Income:

Depreciation, Depletion & Amortization:

Change in Accounts Receiveable:

Net Cash from Operations:

Net Cash from Operations Per Share:

Repurchases/Buybacks Common Stock:

Issuance of Long-term Debt:

Cash Dividends Paid:

Net Cash from Financing Activities:

Property, Plant & Equipment Purchases:

Purchases of Businesses, Net of Cash:

Net Cash from Investing Activities:

Net Change in Cash & Equivalents:

CRBU Balance Sheet

Enable JavaScript and reload

Cash and Cash Equivalents:

Short-Term Investments:

Accounts Receivable, Net:

Inventories:

Total Current Assets:

Property, Plant & Equipment, Net:

Total Assets:

Accounts Payable:

Current Portion of Long-Term Debt:

Total Short-Term Liabilities:

Long Term Debt, Non-Current Portion:

Total Long-Term Liabilities:

Total Liabilities:

Major Holders (from 13F filings)

Investment Type

Change

Value (x$1000)

increase or decrease

Partner Fund Management, L.P.

5,012,118 sh

552,335 sh
12%

$26,614

-$1,393

State Street

3,355,292 sh

156,399 sh
5%

$17,817

-$2,272

Avidity Partners Management Lp

2,758,600 sh

-124,000 sh
-4%

$14,648

-$3,455

Rokos Capital Management Llp

2,748,139 sh

$14,086

Vanguard Group

2,606,061 sh

52,633 sh
2%

$13,839

-$13,100

Elmwood Wealth Management.

2,364,240 sh

$12,554

Pictet Asset Management SA

2,066,176 sh

-487,702 sh
-19%

$10,972

-$5,067

FMR

1,443,823 sh

777 sh
0%

$7,667

-$9,054,665

Morgan Stanley

1,249,248 sh

20,081 sh
2%

$6,632

-$1,088

Geode Capital Management

1,069,624 sh

38,637 sh
4%

$5,680

-$794

FIL

860,666 sh

$4,570

Assenagon Asset Management S.A.

843,025 sh

-11,713 sh
-1%

$4,476

-$892

Maverick Capital

652,542 sh

$3,465

JPMorgan Chase

602,978 sh

2,881 sh
0%

$3,202

-$567

Tekla Capital Management

567,147 sh

$3,012

Memorial Sloan-Kettering Cancer Center

544,196 sh

$2,890

Northernrp

529,005 sh

-5,482 sh
-1%

$2,809

-$3,353,769

72 Investment Holdings

474,067 sh

$2,517

International Biotechnology Trust Plc

457,892 sh

200,000 sh
78%

$2,427

-$1,617,135

Millennium Management

325,015 sh

84,972 sh
35%

Free historical financial statements for Caribou Biosciences Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 8 quarters since 2021. Compare with CRBU stock chart to see long term trends.

Data imported from Caribou Biosciences Inc. SEC filings. Check original filings before making any investment decision.